Year All2024202320222021202020192018201720162014201320112010 May 27, 2021 Rhythm Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference May 21, 2021 Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency May 5, 2021 Rhythm Pharmaceuticals to Present at BofA Securities 2021 Virtual Health Care Conference May 3, 2021 Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results April 7, 2021 Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference March 20, 2021 Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021 March 9, 2021 Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ENDO 2021 March 1, 2021 Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results February 24, 2021 Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference February 10, 2021 Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
May 21, 2021 Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
March 20, 2021 Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021
February 24, 2021 Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
February 10, 2021 Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
